^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-08046052

    i
    Other names: PF-08046052, SGN-EGFRd2, LAVA-1223, LAVA-224×223, LAVA1223, LAVA224×223, PF08046052, LAVA 1223, LAVA 224×223, PF 08046052
    Associations
    News
    Trials
    Company:
    LAVA Therap, Pfizer
    Drug class:
    EGFR inhibitor, γδ TCR modulator
    Related drugs:
    Associations
    News
    Trials